Migraine Clinical Trials in Cincinnati, Ohio
20 recruitingCincinnati, Ohio
Showing 1–20 of 20 trials
Recruiting
Not Applicable
Mind Body Balance for Pediatric Migraine
Migraine with auraMigraineChronic Migraine+5 more
Children's Hospital Medical Center, Cincinnati260 enrolled2 locationsNCT04715685
Recruiting
Not Applicable
BE WELL With Migraine: Brain Education and WELLness With Migraine
Migraine
Wake Forest University Health Sciences286 enrolled3 locationsNCT05987592
Recruiting
Phase 3
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Episodic Migraine
H. Lundbeck A/S315 enrolled65 locationsNCT05897320
Recruiting
Phase 3
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Migraine
H. Lundbeck A/S600 enrolled70 locationsNCT05164172
Recruiting
Phase 3
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Chronic Migraine in Children
H. Lundbeck A/S285 enrolled84 locationsNCT04965675
Recruiting
Phase 3
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Episodic Migraine
AbbVie450 enrolled98 locationsNCT05711394
Recruiting
Phase 3
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Migraine
Pfizer200 enrolled103 locationsNCT06616194
Recruiting
Phase 3
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Pediatric Migraine
Pfizer2,100 enrolled246 locationsNCT04649242
Recruiting
Not Applicable
Supraspinal Processing of Sensory Aspects of Pain
Musculoskeletal PainFibromyalgiaFunctional Abdominal Pain Syndrome+2 more
Children's Hospital Medical Center, Cincinnati255 enrolled1 locationNCT05814497
Recruiting
Phase 3
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Migraine
Pfizer640 enrolled91 locationsNCT05156398
Recruiting
Phase 3
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Acute Treatment of Migraine
Pfizer600 enrolled126 locationsNCT04743141
Recruiting
Phase 3
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Migraine
AbbVie1,059 enrolled129 locationsNCT05125302
Recruiting
Phase 3
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
Migraine
AbbVie496 enrolled106 locationsNCT06417775
Recruiting
Phase 3
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
Chronic Migraine
Merz Therapeutics GmbH780 enrolled108 locationsNCT07018713
Recruiting
Phase 3
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Episodic Migraine
Merz Therapeutics GmbH990 enrolled108 locationsNCT07018700
Recruiting
Phase 2
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
Chronic MigraineEpisodic Migraine
Ipsen641 enrolled166 locationsNCT06625060
Recruiting
Not Applicable
Responding With Evidence and Access for Childhood Headaches
Migraine with auraMigraineChronic Migraine+5 more
Children's Hospital Medical Center, Cincinnati400 enrolled15 locationsNCT05889624
Recruiting
Phase 2
Migraine Manager (R01)
MigraineMigraine Disorders
Children's Hospital Medical Center, Cincinnati160 enrolled1 locationNCT04567355
Recruiting
Phase 4
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
Migraine Disorders
Upsher-Smith Laboratories132 enrolled15 locationsNCT04748601
Recruiting
Overlapping Pain Trajectory Study
Musculoskeletal PainChronic PainHealthy Volunteers+4 more
Children's Hospital Medical Center, Cincinnati420 enrolled1 locationNCT05752396